The release of Sofia Coppola’s Priscilla movie has been pushed back to early November following its debut at the Venice Film Festival.
Deadline reports that the release of Sofia Coppola’s Priscilla has been pushed back. The film, which tells the story of Elvis Presley through the eyes of Priscilla, was originally slated for a October 27th release, but will now be released on November 3rd.
Priscilla recently had its world premiere at the Venice Film Festival where it received rave reviews. The film stars Cailee Spaeny as Priscilla and Jacob Elordi as Elvis. Although it was based on Elvis and Me by Priscilla Presley and Sandra Harmon, the movie doesn’t have the official approval or support of the Elvis Estate. One Estate official slammed Coppola’ writing and directing as “horrible,” adding that the film “feels like a college movie. The set designs are just horrific, it’s not what Graceland looks like.“
Priscilla Presley, who serves as an executive producer, has a different take on the film. “I am very excited to see the interpretation of my book by the masterful Sofia Coppola. She has such an extraordinary perspective and I have always been such an admirer of her work. I’m certain this movie will take everyone on an emotional journey.”
Unfortunately, Priscillawon’t include any of Elvis’ iconic music. Sofia Coppola had approached Elvis Presley Enterprises about using a few Elvis tunes, but was turned down. “They don’t like projects that they haven’t originated,” Coppola said, “and they’re protective of their brand. But that made us be more creative.“
“When teenage Priscilla Beaulieu meets Elvis Presley at a party, the man who is already a meteoric rock-and-roll superstar becomes someone entirely unexpected in private moments: a thrilling crush, an ally in loneliness, a gentle best friend,” reads the official synopsis of Priscilla. “Through Priscilla’s eyes, Sofia Coppola tells the unseen side of a great American myth in Elvis and Priscilla’s long courtship and turbulent marriage, from a German army base to his dream-world estate at Graceland, in this deeply felt and ravishingly detailed portrait of love, fantasy, and fame.
PHOENIX, September 8, 2023 (Newswire.com)
-
Title21 Health Solutions ("Title21"), the leading innovator of cloud enterprise quality management solutions (EQMS), blood and marrow transplant (BMT) and cell and gene therapy (CGT) data management solutions, today announces the successful development of technology to unify key Identity Access Management (IAM) data with Title21's technology platform via SCIM standard.
Developed in collaboration with a leading U.S. hospital group, this technology integrates the hospital's IAM system with Title21's automated quality management platform, allowing a seamless flow of real-time updates to key employee information between systems. This connection eliminates transcription risk and reduces human resource burdens and operational costs in support of key resource optimization efforts central to health systems across the country. Additionally, potential security discrepancies between systems can be eliminated by isolating these permissions to a single source of truth system mapped between systems, effectively increasing lab safety, and therefore patient safety, across the healthcare enterprise.
Title21's CEO Lynn Fischer explains, "Enabling single-source management of employee data, including activation and removal of users and updates to existing permissions, dramatically reduces the time and cost of managing user access across multiple electronic systems." To date, this integration has increased organizational efficiency and quality, and allocated staff time at our partner healthcare institution. Alongside the implementation of Title21's document management system, this integration has also resulted in reduced errors, improved staff learning processes, improved compliance, and increased total document production, resulting in millions of dollars in savings.
The live implementation of this integration further supports Title21's mission of delivering robust, integrated, and easy-to-use software to healthcare and life sciences industries. In securing the connections among electronic systems, removing barriers to productivity, and optimizing quality initiatives, Title21 strengthens its longstanding commitment to improving patient safety and outcomes with both EQMS and cell therapy modules.
With over 20 years focused exclusively on the health and life science domains, Title21 is driven by a patient-first focus through the digital transformation of enterprise hospital programs.
Title21 Health Solutions is an ArchiMed portfolio company. ArchiMed is a leading healthcare industry-focused growth equity enterprise based in New York and Lyon, France.
About Title21 — www.title21.com: Since 2001, Title21 Health Solutions has been dedicated to delivering easy-to-use, flexible, and integrated technology to support healthcare providers and the health sciences to achieve compliance, gain efficiencies and ensure high quality, ultimately, supporting improvement in patient safety and care. The sole focus is developing technology to meet the specific needs of healthcare and life sciences firms, resulting in comprehensive solutions that are flexible to evolving business and regulatory requirements. Through the years, our partnerships with industry leaders have steered our innovations to continue to meet the dynamic needs of the markets we serve. As the breadth of Title21's technology solutions has expanded, our mission and dedication to customers' success and supporting the improvement of patient care has served as the true north. For the team at Title21 Health Solutions, its passion is to deliver technology that better enables customers to deliver products and services that truly make a difference and enable world-class patient care.
About ArchiMed — www.archimed.group: With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation.
BURLINGTON, N.J., September 8, 2023 (Newswire.com)
-
The process of insurance billing, utilization review, appeals, and payment can be quite challenging for behavioral health providers in the United States, regardless of location. The complexities are more pronounced in some cities than others, and there are differences between private insurance and public healthcare plans. A local behavioral and mental health agency in New Jersey has partnered with Apex Healthcare Strategies to establish a new third-party billing service called Integrated RCM Services (IRCMS LLC) after experiencing the barriers and lack of experience or knowledge of other third-party billing companies that bill for these services.
Certified by the New Jersey Department of Banking and Insurance, IRCMS now offers behavioral health providers a solution to the daunting task of recovering insurance claims. IRCMS leverages its hard-won expertise from working with insurance companies to provide healthcare services to clients, ensuring that providers receive compensation for their services.
At IRCMS, we provide a comprehensive suite of services to assist healthcare providers in maximizing their revenue collection. Our services are designed to ensure that providers receive payment in a timely and compliant manner while leveraging data-driven insights to optimize their revenue streams. Our offerings include patient data management, eligibility and benefits verification, coding, audits, billing, payment posting, accounts receivable (AR) follow-up, denials management, patient balance management, and analytics and insights.
IRCMS combines over 50 years of enterprise experience in healthcare revenue management with expert behavioral health insurance billing, claim appeals, and other revenue cycle management functions to outside facilities in New Jersey and surrounding states. With the experience and reach of one of the largest accessible behavioral health providers in the state, IRCMS is uniquely positioned to allow other for-profit and not-for-profit facilities to bill for their services effectively and efficiently, bringing much-needed services to their communities.
To learn more about Integrated RCM Services, visit www.ircmservices.com or call 888-988-6320.
Contact Information:
Nicholas DeRose
Chief Executive Officer [email protected]
(856)-505-6064
HAINESPORT, N.J., September 8, 2023 (Newswire.com)
-
The process of insurance billing, utilization review, appeals, and payment can be quite challenging for behavioral health providers in the United States, regardless of location. The complexities are more pronounced in some cities than others, and there are differences between private insurance and public healthcare plans. A local behavioral and mental health agency in New Jersey has partnered with Apex Healthcare Strategies to establish a new third-party billing service called Integrated RCM Services (IRCMS LLC) after experiencing the barriers and lack of experience or knowledge of other third-party billing companies that bill for these services.
Certified by the New Jersey Department of Banking and Insurance, IRCMS now offers behavioral health providers a solution to the daunting task of recovering insurance claims. IRCMS leverages its hard-won expertise from working with insurance companies to provide healthcare services to clients, ensuring that providers receive compensation for their services.
At IRCMS, we provide a comprehensive suite of services to assist healthcare providers in maximizing their revenue collection. Our services are designed to ensure that providers receive payment in a timely and compliant manner while leveraging data-driven insights to optimize their revenue streams. Our offerings include patient data management, eligibility and benefits verification, coding, audits, billing, payment posting, accounts receivable (AR) follow-up, denials management, patient balance management, and analytics and insights.
IRCMS combines over 50 years of enterprise experience in healthcare revenue management with expert behavioral health insurance billing, claim appeals, and other revenue cycle management functions to outside facilities in New Jersey and surrounding states. With the experience and reach of one of the largest accessible behavioral health providers in the state, IRCMS is uniquely positioned to allow other for-profit and not-for-profit facilities to bill for their services effectively and efficiently, bringing much-needed services to their communities.
To learn more about Integrated RCM Services, visit www.ircmservices.com or call 888-988-6320.
Contact Information:
Nicholas DeRose
Chief Executive Officer [email protected]
(856)-505-6064
The Great has been canceled by Hulu after three seasons, bringing the Elle Fanning and Nicholas Hoult led series to a close.
Son of a bitch. What’s the opposite of Huzzah? Deadline reports that Hulu has canceled The Great after three seasons. The series was a satirical black comedy-drama that chronicled the rise of Catherine the Great from outsider to the longest-reigning female ruler in Russia’s history. Equal parts bizarre, touching, and downright hilarious, The Great has been one of my favourite recent series so it’s tough to see it go.
The Great starred Elle Fanning as Catherine and Nicholas Hoult as Emperor Peter III, her depraved and dangerous husband. The third season was released on Hulu in May and, like the previous two, received critical acclaim.
Here’s the official logline for The Great season 3: “Catherine and Peter attempt to make their marriage work after some seemingly insurmountable problems. Peter witnessed his own attempted murder at Catherine’s hands and she also imprisoned all of his friends. On top of this, Peter is at a loose end playing First Husband to Catherine’s reign, so he busies himself with fathering, hunting and salty culinary ventures. But they’re not enough to keep him contented as visions of his late father, get in his head about his failures as Peter the Great’s son. Catherine the Great starts making a name for herself beyond her borders and inspired by a visit from the US ambassador, sets up a conference where peasants, nobles and merchants can all give their input on developing a new Russia. She learns that even the best political leaders sometimes need to make compromises in order to progress.“
Series creator Tony McNamara had told The Hollywood Reporter’s TV’s Top 5 podcast in 2021 that he didn’t know exactly how long the series would last. “I know a whole bunch of events that are interesting that you can hang things on,” McNamara said. “At the moment, I try not to look too far ahead. At the end of season two, I didn’t quite know what season three was. I like not knowing what comes next. If you have a show with a great ensemble and a great bunch of characters, you can invent as you go for a while.“
While it’s a bummer that The Great has been canceled, the third season did provide would could be seen as a natural end point. Is there more story that could be told? Definitely, but it didn’t exactly leave things hanging and it shouldn’t stop you from watching the series.
Bonnie Wright says that Ginny Weasley’s lack of screen time in the Harry Potter franchise was disappointing.
Ginny Weasley was a prominent supporting character in the Harry Potter novels, but the big screen adaptations didn’t exactly do justice to the character. While appearing on Michael Rosenbaum’s Inside of You podcast (via Entertainment Weekly), Bonnie Wright expressed disappointment at how her character was handled in the movies.
“I definitely feel there was anxiety toward performing and doing the best thing as my character built,” Wright said. “Like, Oh gosh, will I do justice to this character that people love? So that was always hard to do, especially when, inevitably, a lot of the scenes of every character were chopped down from the book to the film. So you didn’t really have as much to show in the film. Sometimes that was a little disappointing because there were parts of the character that just didn’t get to come through because there weren’t the scenes to do that.“
Bonnie Wright made her first appearance as Ginny Weasley in Harry Potter and the Philosopher’s Stone when she was just nine years old. She wasn’t even supposed to have any lines until director Chris Columbus insisted. “The actual first line I had in the film, which was one line, was given to me on the day, [and director Chris Columbus] was like, ‘I think you need a line,’ which is my ‘good luck’ to Harry,” Wright said.
At the time, J.K. Rowling was still in the midst of writing the novels, so Wright wasn’t aware that her character would go on to have a bigger role and end up marrying Harry Potter. As far as raising concerns about her character, Wright explained that “there was no room for much change in those scripts. There were a million executives going through them all. I think what I maybe took, which I don’t take so much to heart now, is I kind of felt that maybe my anxiety was about, Oh, I’m going to be seen as badly portraying this character, rather than later realizing that I wasn’t really given the opportunity to do that. So it wasn’t really my fault, exactly.“
While the Harry Potter movies may not have had the foresight to develop Ginny Weasley properly, perhaps the Harry Potter TV series will be able to flesh out the character. The plan is for each season of the series to focus on one novel, which will leave plenty of screen time for all involved, even Ginny.
A sequel to The Black Demon is being discussed after the movie held the number-one spot on Amazon’s streaming rankings for seven days.
Despite facing stiff competition from major studio movies such as Dungeons & Dragons: Honor Among Thieves and Cocaine Bear, one low-budget shark movie has reigned above them all. The Black Demon held the number-one spot on Amazon’s streaming rankings for seven days, which has prompted discussion of a sequel.
The Black Demon is a shark thriller with a supernatural edge that follows a family stranded on a crumbling oil rig in Baja facing off against a vengeful megalodon shark. Produced for just under $10 million, The Black Demon may not have received the best reviews upon release, but it’s clear that there’s an audience for the movie.
“No one has ever seen a genre shark movie with a Latino bent,” Black Demon producer Javier Chapa told THR. “That’s where we saw the opportunity, given our company’s ethos is all about really supporting people of color on both sides of the camera — but also filling a highly underserved need in our community.” Chapa added, “That the Latino community doesn’t get a lot of support on films, it’s shocking to me. They are the most aggressive moviegoing audience, more than any other cohort. And to me, it’s the million-dollar question: why aren’t more people making films that are universal but that are by and for that community?“
Whether the success of The Black Demon will translate to a sequel remains to be seen, but producers say there has been talk, but that nothing can move forward until the WGA and SAG-AFTRA strikes conclude.
Our own Cody Hamman reviewed The Black Demon earlier this year and called it “middle-of-the-road entertainment” that should have embraced the cheese rather than try to be so serious. “The problem is, if The Black Demon was going to have moments that are so cheesy, it should have leaned further into that cheesiness and been sillier overall,” Hamman wrote. “But it is dead serious most of the time, so any cheesiness seems to have been unintentional. Which means viewers are going to be laughing at the movie instead of with it. We’re supposed to take this all seriously. We’re supposed to be creeped out.” You can check out the rest of Hamman’s review right here.
Would you like to see a sequel to The Black Demon?
NEWPORT BEACH, Calif., September 7, 2023 (Newswire.com)
-
Physicians for Informed Consent (PIC) has introduced two new educational documents, "Polio: What Parents Need to Know" and "IPV Vaccine: Is It Safer Than Polio?" Packed with key statistical data on the risk of polio as well as the risk of the IPV (inactivated poliovirus) vaccine, the documents assist parents in making a more informed risk-benefit calculation for vaccination.
"Now more than ever, people have concerns about vaccines on the childhood vaccination schedule, and a question we hear all the time is 'What about polio?'" said Greg Glaser, general counsel and national coalition director for Physicians for Informed Consent. "These new documents scientifically address this question, so more parents can research the vaccine and decide what's best for their children."
The following is a summary of essential facts included in the documents.
About 95% of people who contract polio have no symptoms (asymptomatic).
The great majority of polio infections that are fatal or result in permanent paralysis occur in people who have had their tonsils surgically removed (tonsillectomy) or do not rest after feeling sick.
Before the introduction of the polio vaccine in 1955, paralytic poliomyelitis was a disease of low incidence, occurring in about 1 in 22,000 or 0.005% in the U.S. population.
Before the polio vaccine was introduced, about 0.0005% (1 in 190,000)of children at normal risk contracted polio that was fatal or led to permanent paralysis.
The polio vaccine does not prevent asymptomatic infection or transmission.
The Institute of Medicine has not ruled out the possibility that IPV vaccination can lead to Guillain-Barré syndrome or sudden infant death syndrome (SIDS).
Seizures may occur in about 1 in 829 children vaccinated with IPV vaccine.
A study published in the Journal of the American Medical Association (JAMA) showsanIPV-containing vaccine may cause permanent injury38 times more often than permanent injury from polio infection.
The polio vaccine has not been proven safer than polio infection for normal-risk children.
"As polio is so feared in our culture, the data we reveal is paradigm-shifting," said Dr. Shira Miller, founder and president of Physicians for Informed Consent. "Our educational documents show that for normal-risk children the polio vaccine is not proven safer than polio infection — which has serious implications for both children's health and vaccine mandates for school attendance."
To protect and enhance children's health, it's necessary that parents have access to reliable infectious disease and vaccine educational information. PIC makes scientific data freely available through its education program, a growing collection of concise, reader-friendly educational materials that support parents, physicians, and policymakers in calculating the risk-benefit ratio of vaccination. To read the newest DIS and VRS documents on polio and the IPV vaccine, visit physiciansforinformedconsent.org/polio.
Contact Information:
Greg Glaser
General Counsel [email protected]
925-642-6651
SALT LAKE CITY, September 7, 2023 (Newswire.com)
-
With over 17 million women affected by lipedema in the United States, The Roxbury Institute is expanding access to its life-changing treatment. On Sept. 8, 2023, the leading medical institute for lipedema therapy and education will open its doors in Salt Lake City to the first facility in Utah dedicated specifically to treating this often painful disease. This new center marks a major milestone in the Institute's mission to advance knowledge and provide comprehensive treatment for lipedema.
Lipedema, a chronic condition marked by abnormal and disproportionate fat accumulation in the legs and arms, affects an estimated 1 in 9 women worldwide. Acknowledging the widespread impact of this little-understood disease, Advanced Lipedema Treatment has pioneered a dedicated facility to serve as a beacon of hope for those affected both locally and globally.
Under the guiding hand of Dr. David Amron, ALT is setting a new standard in lipedema care. Recognized internationally as the pioneer of lipedema treatment in the United States, Dr. Amron carries over 25 years of surgical experience and more than 12,000 successful surgeries. His leadership drives ALT towards delivering groundbreaking therapy for those battling lipedema.
"I'm excited about the meaningful change we can bring to Salt Lake City. Our center is more than a clinic; it's a place of healing where women can find expert care, renewed hope, and reclaim a stronger, healthier life," said Dr. Amron. "We also aim to be a trusted resource for medical professionals seeking to provide the best lipedema treatment for their patients."
Building on the model and impact achieved at its Beverly Hills location, ALT's vision of being the achievable solution for lipedema involves improved access through conveniently located facilities, and also simplifying the burden of complicated insurance coverage. To support this vision, ALT provides patients with an in-house insurance team at no additional cost. Their role assists in insurance navigation and securing approvals, which makes ALT's transformative treatments more easily attainable.
"In Salt Lake City, we're not just launching a new treatment facility. We're starting a new chapter in our journey to help women with lipedema regain control of their lives. As a doctor, it's truly rewarding to see patients turn a corner towards a healthier, more active future," added Dr. Amron.
Exclusive to the esteemed Institute, ALT's state-of-the-art facility will offer specialized lipedema treatments as the area's leading provider. The new medical institute provides localized access for Utah residents while also ensuring easier access for out-of-state patients seeking care.
With Salt Lake City setting the stage, through its Advanced Lipedema Treatment program, The Roxbury Institute is determined to expand its revolutionary support system for women battling lipedema and extend access to world-class treatment, pioneering a shift in lipedema patient care.
Starting today, consultations can be scheduled for the upcoming Salt Lake City facility. For more information, visit www.AdvancedLipedemaTreatment.com or call 424-333-9944.
ABOUT ADVANCED LIPEDEMA TREATMENT:
Led by renowned expert Dr. David Amron, the globally recognized Advanced Lipedema Treatment (ALT) program offers personalized, life-changing treatment for those battling lipedema. Leveraging decades of experience and over 12,000 successful surgeries, ALT pioneers breakthrough treatments that significantly enhance the quality of life for women afflicted by lipedema — helping these patients regain the active, healthy, and happy lives they deserve.
# # #
Contact Information:
Tyler Barnett
Media Representative [email protected]
Saw X director Kevin Greutert says that the upcoming movie features more of Tobin Bell’s Jigsaw than any other in the franchise.
“I want to play a game.” It’s been nearly twenty years since Jigsaw first uttered those words and began a bloody journey full of gruesome traps and terrific twists. However, after Jigsaw/John Kramer was killed off in Saw III, subsequent sequels featured the character less and less, to the point where he only appeared for two minutes in Saw 3D. Thankfully, that’s not going to be a problem in Saw X as director Kevin Greutert told Empire that the movie features more of Tobin Bell’s Jigsaw “than in any other Saw.“
“Kramer is the centre of the story,” Kevin Greutert said. “They tried to make the last Saw without Tobin, and to me, that was a pretty gutsy move.” In addition to more Jigsaw, Saw X will also return to a more gritty, realistic tone. “This one has pulled back to a somewhat more realistic level,” Greutert said. “Not maybe Saw I-level simplicity, but close. The more that the audience can get the sense that a smart engineer – which he is – could figure out what to do with these parts and make it work, the better.“
Saw X will also shift the perspective of the story more towards Jigsaw himself. “[Saw X] is an emotional journey that you go on with John Kramer, and less a slaughterhouse that you experience from the point of view of the victims,” Greutert said. “Obviously there will be people that can’t handle it, but I think it has a good chance of appealing to people beyond gore freaks.“
As the trailer revealed, Saw X will be set between the events of the first two movies. “John Kramer (Tobin Bell) is back. The most chilling installment of the SAW franchise yet explores the untold chapter of Jigsaw’s most personal game,” reads the official synopsis. “Set between the events of SAW I and II, a sick and desperate John travels to Mexico for a risky and experimental medical procedure in hopes of a miracle cure for his cancer – only to discover the entire operation is a scam to defraud the most vulnerable. Armed with a newfound purpose, John returns to his work, turning the tables on the con artists in his signature visceral way through a series of ingenious and terrifying traps.“
